Navigation Links
Lakewood-Amedex Inc. to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains
Date:8/27/2009

SARASOTA, Fla., Aug. 27 /PRNewswire/ -- Lakewood-Amedex Inc., (L-A), the anti-infectives biopharmaceutical company developing a unique portfolio of anti-bacterial and anti-viral products including NuBiotics, a novel family of synthetic anti-bacterial compounds, and anti-viral products against hepatitis, HIV and influenza, announced today that it is accelerating development of its broad spectrum anti-influenza product into clinical studies.

Lakewood-Amedex's nRNA product works by selectively silencing targeted genes in the viral genome. The company is building on the previously successful animal model study where mice infected with H1N1 type A influenza virus were given two doses of the L-A nRNA product and all survived while control and placebo dosed mice all died within six days. In addition L-A previously published a study demonstrating the effectiveness of its technology against the lethal H5N1 "bird flu" influenza virus in which a single intra-nasal dose of the company's nRNA product protected 100% of the infected chickens while placebo treated chickens all died within seven days.

Steve Parkinson, L-A's President and Chief Executive Officer, commented, "We had intended to develop our broadly applicable influ-RNA product to treat seasonal flu and as an emergency stockpile product in the event of a further outbreak of avian influenza, but due to the escalating global H1N1 pandemic and now the report of this virus having been isolated from turkeys in Chile, we feel it is critical to have a product that can target multiple strains of influenza and is useable year after year."

Mr. Parkinson explained that the L-A product does not work like a vaccine that stimulates the human host immune system to produce antibodies targeted at the specific viral strain composing the vaccine. Instead the nRNA product contains several short oligonucleotide sequences that are mirror images to unique
'/>"/>

SOURCE Lakewood-Amedex Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing
2. New Consortium to Develop Drugs for Neglected Tropical Diseases
3. OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
4. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
5. Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
6. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
7. Cryo-Cell Announces Celle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
8. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
9. Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value
10. Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
11. ADHD Genes Found; Known to Play Roles in Neurodevelopment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 /PRNewswire/ ... company") announced today that the company,s board of directors approved ... to June 30. Accordingly, DelMar will file a Transition Form ... Jeffrey Bacha , president and CEO of DelMar stated, "The ... achieving our goal of obtaining a senior exchange listing for ...
(Date:7/24/2014)... Sciences, Inc. (NASDAQ: ALIM ) ("Alimera"), a ... commercialization of prescription ophthalmic pharmaceuticals, today announced that it ... financial results after the market close on Thursday, August ... the same day at 4:30 p.m. ET. ... Dan Myers , President and Chief Executive Officer, and ...
(Date:7/24/2014)... , July 24, 2014  Perrigo Company (NYSE: ... received an AB therapeutic equivalent rating from the U.S. ... New Drug Application (NDA) for testosterone gel 1.0%. FDA ... [AbbVie,s] AndroGel 1% and can be substituted with the ... effect and safety profile as AndroGel 1% when used ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3Alimera Sciences To Release Second Quarter 2014 Results 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3
... N.J. , July 12 Timothy G. Hayes , currently ... North America , will also lead the business unit,s Global Business Development ... , , ... the United States , Canada and Puerto Rico , ...
... July 13 A new free, white paper that guides ... Food and Drug Administration (FDA) regulations to combination products embedded with ... http://www.microtestlabs.com/combination-products-20/ ) , , ... Combination products are a large and growing segment of the medical ...
Cached Medicine Technology:Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care 2Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care 3New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 2New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 3New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 4
(Date:7/25/2014)... 25, 2014 A report released by the ... fiscal year 2013 (July 1, 2012- June 30, 2013). , ... the JDRF is the largest single funder of type 1 ... and relationships with most of the top research centers. ... for type 1 diabetes in the near future. , Since ...
(Date:7/25/2014)... Steven Reinberg HealthDay Reporter ... low" number of girls and boys are getting the human ... cancers, U.S. health officials said Thursday. The U.S. Centers ... aged 11 and 12 get the three-dose vaccine so that ... Yet, despite a slight increase over the ...
(Date:7/25/2014)... reactions and desires in initial romantic encounters determine the ... of those initial "sparks" necessary to fuel sexual desire ... be a desirable trait for both men and women ... in the other person? Do men perceive responsive women ... for women,s perceptions of men? A study published in ...
(Date:7/25/2014)... Home Care Assistance – Halton/Peel Region ... in-home senior care, is weighing in on the recent ... projects in Alberta through their New Horizons for Seniors ... is a federal grants and contributions program that supports ... difference in the lives of others and in their ...
(Date:7/25/2014)... ZeptoMetrix™ Corporation (ZMC), an industry leader ... and services for infectious disease diagnostic development, is ... Multimarker Controls - MDZ001 . , An ... marked, unassayed external run control intended for use ... Multimarker Controls - MDZ001 has been specifically designed ...
Breaking Medicine News(10 mins):Health News:Report: JDRF 2013 Annual Research Spending Down by $50 million 2Health News:Too Few Teens Receive HPV Shot, CDC Says 2Health News:Too Few Teens Receive HPV Shot, CDC Says 3Health News:Why do men prefer nice women? 2Health News:Why do men prefer nice women? 3Health News:Home Care Assistance – Halton/Peel Region Weighs in on Alberta Communities Receiving Funding to Support Seniors and Senior Caregivers 2Health News:Home Care Assistance – Halton/Peel Region Weighs in on Alberta Communities Receiving Funding to Support Seniors and Senior Caregivers 3Health News:ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker Controls 2
... avoid exposure to the fumes of solvents used in ... lacquers//, could give rise to allergies in young children, ... environmental agency. ,Pregnant women should leave renovation ... clear of the work area altogether. ,'It ...
... also suffer from diseases that could be aggravated by alcohol ... drinking alcohol, face the risk of higher death rates, when ... have any such complications. ,Older men who drank moderately ... by alcohol use such as gout or ulcer disease, or ...
... has warned the nation's betel-nut chewers of the increased ... habits like smoking and drinking. ,According to ... National Health Research Institute when betel nut chewing was ... cancer of the esophagus was about 195 times higher ...
... most companies have stopped supply citing 'anomalies' in the Value ... have withdrawn the supply of drugs due to confusion over ... shortage has put patients in a difficult situation as medicines ... stock. The patients are getting medicines from neighbouring states. ...
... Philippines is witness to a yearly exodus phenomenon of ... their land for raking// in the moolah elsewhere! This ... against serious implications on the country’s health services. According ... grave with nearly 85% of the nursing population, settled ...
... the Federal Government has put together a coherent and long-term ... as well as ease the burden on their carers. He ... mental health, including new Medicare rebates for consultations with psychologists ... could be a big difference, with a concerted contribution from ...
Cached Medicine News:Health News:Alcoholism Linked To Higher Death Rates Among Older Men 2Health News:Cancer Risks for Betel Nut Chewers 2Health News:Medicare Benefits For Patients seeking Psychiatric Help 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: